As shown in previous studies, WP1066 inhibits proliferation and induces apoptosis of pancreatic cancer cells, reduces the expression of STAT3-dependent anti-apoptotic proteins (Bcl-xL, survivin), and blocks constitutive and IL-6-induced STAT3 phosphorylation [69]. The gene discussed is STAT3; the disease is pancreatic neoplasm.